Strength
400; 100 mg/1; mg/1
Manufacturer
Asegua Therapeutics LLCNDC
72626270101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
SOFOSBUVIR; VELPATASVIRApproval Type
Authorized Generic (NDA)
FDA Application
NDA208341On Market Since
11/14/2018
Pharmacological Classes
Breast Cancer Resistance Protein Inhibitors
Hepatitis C Virus NS5A Inhibitor
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Organic Anion Transporting Polypeptide 1B1 Inhibitors
Organic Anion Transporting Polypeptide 1B3 Inhibitors
Organic Anion Transporting Polypeptide 2B1 Inhibitors
P-Glycoprotein Inhibitors
RNA Replicase Inhibitors
Related Drugs
Same classification
ZONISAMIDE 25 MG CAPSULE
Generic
29300042801•Unichem Pharmaceuticals (USA) Inc.
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
59651037801•Aurobindo Pharma Limited
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
62756025802•Sun Pharmaceutical Industries Inc.
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
68001024200•BluePoint Laboratories
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
68462012801•Glenmark Pharmaceuticals Inc., USA
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
72578004001•Viona Pharmaceuticals Inc.
$0.0641
per EA
ZONISAMIDE 25 MG CAPSULE
Generic
76282022601•Exelan Pharmaceuticals Inc.
$0.0641
per EA
VERAPAMIL 80 MG TABLET
Generic
00591034301•Actavis Pharma, Inc.
$0.0740
per EA
VERAPAMIL 80 MG TABLET
Generic
00591034305•Actavis Pharma, Inc.
$0.0740
per EA
VERAPAMIL 80 MG TABLET
Generic
00591034310•Actavis Pharma, Inc.
$0.0740
per EA